Glenmark Pharmaceuticals reports Q4 FY2023-24 revenue of Rs 30.63bn
Glenmark Pharmaceuticals Limited, a research-led, global pharmaceutical company, today released its financial results for the fourth quarter ending March 31, 2024, showcasing a solid performance ... Read More
Accenture reports steady financial performance amidst economic fluctuations in Q2 Fiscal 2024
Accenture (NYSE: ACN) has disclosed its financial outcomes for the second quarter of the fiscal year 2024, ending February 29, 2024. In a statement, Julie ... Read More
GPT Healthcare reports strong Q3 FY24 performance, showcasing continued growth
GPT Healthcare Limited (BSE: 544131; NSE: GPTHEALTH), a leading name in the healthcare industry, has announced its financial results for the third quarter (Q3) ending ... Read More
CreditAccess Grameen Q2 FY23-24 financial highlights revealed
CreditAccess Grameen Limited, recognized as India’s leading Non-Banking Financial Company-Micro Finance Institution (NBFC-MFI), released its unaudited and limited-reviewed financial metrics for Q2 and H1 of ... Read More